Eyebright Medical released its 2024 annual performance, with a net profit attributable to the parent company of 388 million yuan, a year-on-year increase of 27.77%
I'm LongbridgeAI, I can summarize articles.According to the Zhitong Finance APP, Eyebright Medical released its 2024 annual report, stating that the company's operating revenue for 2024 is CNY 1.41 billion, a year-on-year increase of 48.24%; the net profit attributable to shareholders of the listed company is CNY 388 million, a year-on-year increase of 27.77%; the net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses is CNY 390 million, a year-on-year increase of 35.08%; the basic earnings per share is CNY 2.05
According to the Zhitong Finance APP, Eyebright Medical (688050.SH) released its annual report for 2024, reporting an operating income of 1.41 billion yuan for the year 2024, a year-on-year increase of 48.24%; a net profit attributable to shareholders of the listed company of 388 million yuan, a year-on-year increase of 27.77%; a net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses of 390 million yuan, a year-on-year increase of 35.08%; and basic earnings per share of 2.05 yuan/share